Filing Flows › Dianthus Therapeutics (DNTH) › Recalls, complaints & regulation
Dianthus Therapeutics (DNTH): clinical trials
Dianthus Therapeutics (DNTH) beyond its filings: 4 active clinical trials.
Dianthus Therapeutics' latest quarter
Dianthus Therapeutics, Q4 2025: revenue $284K (-79% year over year), net loss $64.4M, operating cash flow −$47.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Dianthus Therapeutics have?
4 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.